6.4
Adrenerge Receptoren: β-Subtype
β-adrenoceptoren hebben verschillende gevoeligheden voor adrenaline, noradrenaline en isoprenaline. De volgorde van agonist-potentie is als volgt:
Iso…
β adrenergic receptors or β-adrenoceptors show a stronger response to ISO, compared to Adr and NA.
Upon stimulation, all β-adrenoceptors activate adenylyl cyclase leading to increased cAMP production and modulation of calcium channels.
These receptors are further classified into three subtypes based on various factors.
β1 receptors have almost equal affinity for both Adr and NA. They are located predominantly in cardiac tissue, lipocytes, and renal cells.
Their stimulation causes tachycardia, lipolysis, and renin production.
β2 receptors have a higher affinity for Adr than NA. They are located postsynaptically in the smooth muscles of the cardiovascular, respiratory, and genitourinary systems. They are responsible for causing bronchodilation, vasodilation, decreased peripheral resistance, relaxation of the bladder and gravid uterus.
β3 receptors show higher sensitivity to NA than Adr. They are located postsynaptically on the lipocytes and bladder. They regulate metabolic activity and lipolysis, and relax the bladder's detrusor muscle.
View the full transcript and gain access to JoVE Core videos
Q1: What are the three subtypes of beta-adrenergic receptors?
Beta-adrenergic receptors are classified into three subtypes: β1, β2, and β3. β1 receptors have equal affinity for adrenaline and noradrenaline and are located in cardiac tissue, lipocytes, and renal cells. β2 receptors show higher affinity for adrenaline and are found in smooth muscles of the cardiovascular and respiratory systems. β3 receptors demonstrate higher sensitivity to noradrenaline and are located on lipocytes and bladder tissue.
Q2: How do beta-adrenergic receptors activate intracellular signaling?
When neurotransmitters bind to beta-adrenergic receptors, they activate adenylyl cyclase, an enzyme that increases cAMP production within the cell. This elevated cAMP concentration triggers modulation of calcium ion channels, initiating downstream cellular responses. This mechanism is common to all three beta-receptor subtypes and is responsible for their diverse physiological effects.
Q3: What physiological effects result from stimulating β1 receptors?
Stimulation of β1 receptors causes increased myocardial contractility, leading to tachycardia (increased heart rate). These receptors also promote lipolysis (fat breakdown) in lipocytes and stimulate renin production in renal cells. β1 receptors are predominantly located in cardiac tissue, making them critical regulators of heart function and metabolic activity.
Q4: What are the main effects of β2 receptor activation?
β2 receptor stimulation causes bronchodilation, vasodilation, and decreased peripheral resistance, making these receptors important for respiratory and cardiovascular regulation. They also increase glucagon release and glycogenolysis in liver and muscle tissue, and promote uterine relaxation in females. These receptors are located postsynaptically in smooth muscles of blood vessels and airways.
Q5: How do β1 and β3 receptors differ in their agonist sensitivity?
β1 receptors have almost equal affinity for both adrenaline and noradrenaline, while β3 receptors show higher sensitivity to noradrenaline than adrenaline. In contrast, β2 receptors demonstrate higher affinity for adrenaline. These differences in agonist potency reflect the distinct tissue distributions and physiological roles of each receptor subtype.
Q6: What is the role of β3 receptors in metabolic regulation?
β3 receptors regulate metabolic activity and lipolysis in lipocytes, working alongside β1 receptors to control fat breakdown. Located postsynaptically on lipocytes and bladder tissue, β3 receptors also relax the bladder's detrusor muscle. Their higher sensitivity to noradrenaline distinguishes them functionally from β1 and β2 receptor subtypes.
Q7: Why is isoprenaline more potent than adrenaline at beta-adrenergic receptors?
Beta-adrenergic receptors show stronger responses to isoprenaline compared to adrenaline and noradrenaline. The order of agonist potency is isoprenaline greater than adrenaline greater than noradrenaline. This differential potency reflects structural differences in how each agonist interacts with the receptor binding site and activates adenylyl cyclase signaling.